以下部分引用 AI 总结,现阶段 AI 仍然有幻觉。请以内容的原文为准。
数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15
DFTX
8 atoms · 跨 1 天 · 首见 2026-06-22 · 最近 2026-06-22
三色: 🟦 fact 8 · 🟥 take 0 · stance ▲5/▼0/◆0
来源: X 8
时态: fresh:8
标签: 好数字:8 · 好信源:4
事实 (fact) (8)
- 2026-06-22 · DT120 ODT met primary endpoint in Phase 3 Emerge
$DFTX says its LSD-based DT120 ODT met the primary endpoint in Phase 3 Emerge for major depressive disorder.
tags: 好数字·好信源 · → daily
- 2026-06-22 · DT120 placebo-adjusted MADRS reduction at Week 6
Single-dose DT120 showed an 8.1-point placebo-adjusted MADRS reduction at Week 6, 14.2 points at Week 1, and 7.3 points at Week 12.
tags: 好数字·好信源 · → daily
value: qty=8.1 points · date=Week 6
- 2026-06-22 · DT120 response rate at Week 6
Response at Week 6 was 35% vs. 7% for placebo, with remission at 24% vs. 3%.
tags: 好数字·好信源 · → daily
value: qty=35% vs. 7% placebo · date=Week 6
- 2026-06-22 · DT120 adverse events profile
99% of adverse events were mild to moderate, with no serious adverse events or suicidality signal reported.
tags: 好数字·好信源 · → daily
- 2026-06-22 · 股价上涨
Definium Therapeutics (DFTX) gains 32% after announcing positive topline results from a Phase 3 study evaluating a single dose of an orally disintegrating tablet in adults with major depressive disorder.
tags: 好数字 · → daily
value: qty=32% · date=2026-06-22
- 2026-06-22 · DT120 placebo-adjusted MADRS reduction at Week 1
14.2 points at Week 1
tags: 好数字 · → daily
value: qty=14.2 points · date=Week 1
- 2026-06-22 · DT120 placebo-adjusted MADRS reduction at Week 12
7.3 points at Week 12
tags: 好数字 · → daily
value: qty=7.3 points · date=Week 12
- 2026-06-22 · DT120 remission rate at Week 6
remission at 24% vs. 3%
tags: 好数字 · → daily
value: qty=24% vs. 3% placebo · date=Week 6
时间轴 (近 20)
- 2026-06-22 ·
fact · 股价上涨 · → daily
- 2026-06-22 ·
fact · DT120 ODT met primary endpoint in Phase 3 Emerge · → daily
- 2026-06-22 ·
fact · DT120 placebo-adjusted MADRS reduction at Week 6 · → daily
- 2026-06-22 ·
fact · DT120 placebo-adjusted MADRS reduction at Week 1 · → daily
- 2026-06-22 ·
fact · DT120 placebo-adjusted MADRS reduction at Week 12 · → daily
- 2026-06-22 ·
fact · DT120 response rate at Week 6 · → daily
- 2026-06-22 ·
fact · DT120 remission rate at Week 6 · → daily
- 2026-06-22 ·
fact · DT120 adverse events profile · → daily
← 实体目录 · 系统日志